D69.2 is a billable ICD-10 code used to specify a medical diagnosis of other nonthrombocytopenic purpura. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Acute purpuric eruption of skin
- Autoimmune state
- Clothing purpura
- Contact purpura
- Drug-induced purpura
- Dysproteinemic purpura
- Eczematid-like purpura of Doucas and Kapetanakis
- Embolic purpura
- Gardner-Diamond syndrome
- Idiopathic capillaritis
- Itching purpura
- Mechanical purpura
- Metabolic purpura
- Non-thrombocytopenic purpura
- Primary non-thrombocytopenic purpura
- Purpura due to increased intravascular pressure
- Purpura due to prolonged vomiting and/or coughing
- Purpura of female perineum
- Purpura of mouth region
- Purpura of periwound skin
- Purpura of skin and or skin-associated mucous membrane co-occurrent and due to coagulation disorder
- Purpura of skin caused by mechanical force
- Purpura pigmentosa chronica
- Purpura simplex
- Purpuric disorder
- Purpuric rash
- Purpuric rash
- Secondary non-thrombocytopenic purpura
- Senile purpura
- Stasis purpura
- Stellate pseudoscar
- Stellate pseudoscar in senile purpura
- Steroid purpura
- Vascular hemostatic disease
- Murexide-. 5,5'-nitrilodibarbituric acid ammonium derivative. used as an indicator for complexometric titrations.
- Purpura-. purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. when the size of the discolorization is >2-3 cm it is generally called ecchymoses (ecchymosis).
- Purpura Fulminans-. a severe, rapidly fatal reaction occurring most commonly in children following an infectious illness. it is characterized by large, rapidly spreading skin hemorrhages, fever, or shock. purpura fulminans often accompanies or is triggered by disseminated intravascular coagulation.
- Purpura, Hyperglobulinemic-. purplish or brownish red discoloration of the skin associated with increase in circulating polyclonal globulins, usually gamma-globulins. this syndrome often occurs on the legs of women aged 20 to 40 years.
- Purpura, Thrombocytopenic-. any form of purpura in which the platelet count is decreased. many forms are thought to be caused by immunological mechanisms.
- Purpura, Thrombocytopenic, Idiopathic-. thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. it is mediated by immune mechanisms, in most cases immunoglobulin g autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. the disease is seen in acute (affecting children) and chronic (adult) forms.
- Purpura, Thrombotic Thrombocytopenic-. an acquired, congenital, or familial disorder caused by platelet aggregation with thrombosis in terminal arterioles and capillaries. clinical features include thrombocytopenia; hemolytic anemia; azotemia; fever; and thrombotic microangiopathy. the classical form also includes neurological symptoms and end-organ damage, such as renal failure. mutations in the adamts13 protein gene have been identified in familial cases.
- Transfusion Reaction-. complications of blood transfusion. included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.
- Waterhouse-Friderichsen Syndrome-. a condition of hemorrhage and necrosis of the adrenal gland. it is characterized by rapidly developing adrenal insufficiency; hypotension; and widespread cutaneous purpura.
- Ecchymosis-. extravasation of blood into the skin, resulting in a nonelevated, rounded or irregular, blue or purplish patch, larger than a petechia.
- Disseminated Intravascular Coagulation-. a disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. the activation of the clotting mechanism may arise from any of a number of disorders. a majority of the patients manifest skin lesions, sometimes leading to purpura fulminans.
- gamma-Globulins-. serum globulins that migrate to the gamma region (most positively charged) upon electrophoresis. at one time, gamma-globulins came to be used as a synonym for immunoglobulins since most immunoglobulins are gamma globulins and conversely most gamma globulins are immunoglobulins. but since some immunoglobulins exhibit an alpha or beta electrophoretic mobility, that usage is in decline.
- Platelet Count-. the number of platelets per unit volume in a sample of venous blood.
- Blood Transfusion-. the introduction of whole blood or blood component directly into the blood stream. (dorland, 27th ed)
- Acquired Thrombotic Thrombocytopenic Purpura|Acquired ADAMTS13 Deficiency|Acquired TTP-. thrombotic thrombocytopenic purpura for which the cause is not present at birth.
- Congenital Thrombotic Thrombocytopenic Purpura|Congenital ADAMTS-13 Deficiency|Congenital ADAMTS13 Deficiency|Congenital TTP-. thrombotic thrombocytopenic purpura for which the cause is present from birth.
- FSCN1 Gene|FSCN1|FSCN1|Fascin Homolog 1, Actin-Bundling Protein (Strongylocentrotus purpuratus) Gene-. this gene is involved in actin filament assembly.
- FSCN1 wt Allele|FAN1|FLJ38511|FLJ43305|Fascin Homolog 1, Actin-Bundling Protein (Strongylocentrotus purpuratus) wt Allele|HSN|SNL|Singed (Drosophila)-Like (Sea Urchin Fascin Homolog Like) Gene|Singed, Drosophila, Homolog-Like Gene|p55-. human fscn1 wild-type allele is located in the vicinity of 7p22 and is approximately 14 kb in length. this allele, which encodes fascin protein, plays a role in both actin binding and microfilament remodeling. aberrant expression of the gene is associated with various types of carcinoma.
- Goodpasture Syndrome|Goodpasture's Syndrome|Lung Purpura with Glomerulonephritis-. an autoimmune disorder characterized by pulmonary hemorrhage and glomerulonephritis. it is a hypersensitivity reaction resulting in the formation of antibodies against the pulmonary alveoli and the basement membrane of the glomeruli.
- Grade 1 Purpura, CTCAE|Grade 1 Purpura-. combined area of lesions covering <10% bsa
- Grade 2 Purpura, CTCAE|Grade 2 Purpura-. combined area of lesions covering 10-30% bsa; bleeding with trauma
- Grade 3 Purpura, CTCAE|Grade 3 Purpura-. combined area of lesions covering >30% bsa; spontaneous bleeding
- Grade 3 Thrombotic Thrombocytopenic Purpura, CTCAE|Grade 3 Thrombotic thrombocytopenic purpura-. laboratory findings with clinical consequences (e.g., renal insufficiency, petechiae)
- Grade 4 Thrombotic Thrombocytopenic Purpura, CTCAE|Grade 4 Thrombotic thrombocytopenic purpura-. life-threatening consequences, (e.g., cns hemorrhage or thrombosis/embolism or renal failure)
- Grade 5 Thrombotic Thrombocytopenic Purpura, CTCAE|Grade 5 Thrombotic thrombocytopenic purpura-. death
- Henoch-Schönlein Purpura Nephritis-. glomerulonephritis in the context of henoch-schönlein purpura.
- Henoch-Schönlein Purpura|HSP|Schoenlein-Henoch Purpura-. a systemic, usually self-limited immune complex vasculitis, characterized by immunoglobulin a deposition in the small vessels and kidneys. it is manifested with small hemorrhages in the skin, gastrointestinal symptoms, arthritis, and nephropathy.
- Primary Immune Thrombocytopenia|ITP|ITP|ITP|ITP|Idiopathic Thrombocytopenia|Idiopathic Thrombocytopenia Purpura|Idiopathic Thrombocytopenic Purpura|Idiopathic Thrombocytopenic Purpura|Idiopathic Thrombocytopenic Purpura|Idiopathic Thrombocytopenic Purpura|Immune Thrombocytopenia|Immune Thrombocytopenic Purpura|idiopathic thrombocytopenic purpura|immune thrombocytopenic purpura-. acquired thrombocytopenia of unknown cause, characterized by immune-mediated destruction of normal platelets. it affects both children and adults. it manifests with petechiae, purpura, and overt bleeding. based upon the duration of the disease, it is classified as newly diagnosed (from diagnosis until 3 months), persistent (3-12 months), and chronic (lasting for more than 12 months).
- Purpura-. a small blood vessel hemorrhage into the skin and/or mucous membranes. newer lesions appear reddish in color. older lesions are usually a darker purple color and eventually become a brownish-yellow color.
- Purpura, CTCAE|Purpura|Purpura-. a disorder characterized by hemorrhagic areas of the skin and mucous membrane. newer lesions appear reddish in color. older lesions are usually a darker purple color and eventually become a brownish-yellow color.
- Thrombocytopenic Purpura-. purpura associated with a reduction in circulating blood platelets which can result from a variety of factors.
- Thrombotic Thrombocytopenic Purpura, CTCAE|Thrombotic Thrombocytopenic Purpura|Thrombotic thrombocytopenic purpura-. a disorder characterized by the presence of microangiopathic hemolytic anemia, thrombocytopenic purpura, fever, renal abnormalities and neurological abnormalities such as seizures, hemiplegia, and visual disturbances. it is an acute or subacute condition.
- Thrombotic Thrombocytopenic Purpura|Moschowitz Disease|TTP|TTP|Thrombotic thrombocytopenic purpura-. a coagulation disorder characterized by extensive formation of thrombi in small blood vessels throughout the body due to low levels of adamts13 protein, and resulting in consumption of circulating platelets, which is characterized by thrombocytopenia, anemia, neurologic changes, and sometimes fever and renal dysfunction.
- Vascular Purpura|Palpable Purpura-. a raised vasculitic hemorrhage into the skin and/or mucous membranes.
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to this diagnosis code:
Inclusion TermsInclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Purpura NOS
- Purpura simplex
- Senile purpura
Index to Diseases and Injuries References
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:
- - Autoerythrocyte sensitization (syndrome) - D69.2
- - Autosensitivity, erythrocyte - D69.2
- - Hemorrhage, hemorrhagic (concealed) - R58
- - Purpura - D69.2
- - Sensitization, auto-erythrocytic - D69.2
Convert to ICD-9 Code
|Source ICD-10 Code||Target ICD-9 Code|
|D69.2||287.2 - Purpura NOS|
Normally, if you get hurt, your body forms a blood clot to stop the bleeding. For blood to clot, your body needs cells called platelets and proteins known as clotting factors. If you have a bleeding disorder, you either do not have enough platelets or clotting factors or they don't work the way they should.
Bleeding disorders can be the result of other diseases, such as severe liver disease or a lack of vitamin K. They can also be inherited. Hemophilia is an inherited bleeding disorder. Bleeding disorders can also be a side effect of medicines such as blood thinners.
Various blood tests can check for a bleeding disorder. You will also have a physical exam and history. Treatments depend on the cause. They may include medicines and transfusions of blood, platelets, or clotting factor.
[Learn More in MedlinePlus]
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)